All articles by Phillip Broadwith – Page 15

Business
Amgen stacks up additional job cuts

2014-10-28T00:00:00Z

Up to 1100 more staff face redundancy in ongoing restructuring plan
Business
AbbVie backs out of Shire deal

2014-10-17T00:00:00Z

Treasury rule changes make inversion ‘too uncertain’ and remove financial benefits
Business
Endo outbids QLT for Auxilium merger

2014-10-10T00:00:00Z

Biotech backs out of Canadian deal in favour of increased $2.6bn bid from Endo
Business
EMA finalises trial transparency rules

2014-10-08T00:00:00Z

Researcher access reinstated, but company redaction rights may cause issues
Business
Actavis boosts antibiotics with Durata buyout

2014-10-08T00:00:00Z

$820 million deal gives Actavis control of newly-approved intravenous antibiotic
Business
Becton Dickinson to buy CareFusion for $12bn

2014-10-07T00:00:00Z

Medical devices merger continues consolidation trend
Business
J&J to buy antiviral specialist Alios

2014-10-01T00:00:00Z

$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus
Business
Dow’s $1bn price-fixing fine upheld

2014-10-01T00:00:00Z

Firm loses its appeal against damages for fixing polyurethane prices
Business
Mitsubishi to buy Japanese gases specialist

2014-09-30T00:00:00Z

Taiyo Nippon Sanso acquisition continues consolidation in Japan’s chemical industry
Business
Lumara splits and sells to AMAG and Perrigo

2014-09-30T00:00:00Z

Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products
Business
India backs off drug pricing controls

2014-09-25T00:00:00Z

Current price caps will stand, but rules on how new caps can be imposed are being tightened
Business
Review says cheaper drug is safe for eye disease

2014-09-24T00:00:00Z

Cochrane collaboration says side effects of expensive Lucentis and off-label Avastin are similar
Business
Gilead licenses generic hepatitis C drug in India

2014-09-23T00:00:00Z

Company aims to head off competition and grab a slice of royalties
Business
Freeing a world of fixers

2014-09-16T00:00:00Z

Company profile: Sugru mouldable silicone rubber lets you mend what’s broken and hack stuff better
Business
Novo Nordisk quits inflammation R&D and cuts jobs

2014-09-03T00:00:00Z

Firm will return to primary focus on diabetes and obesity
Business
Halliburton settles Deepwater Horizon claims

2014-09-03T00:00:00Z

Company will pay $1.1bn for damage to property and commercial fishing
Business
Exelexis slashes workforce by 70%

2014-09-02T00:00:00Z

Poor clinical trial performance pushes company into cost-cutting drive
Business
DuPont settles pollution charges for $1.3m

2014-08-28T00:00:00Z

Allegations relate to eight hazardous chemical leaks in West Virginia between 2006 and 2010
Business
Clinical collaborations drive cancer immunotherapy

2014-08-27T00:00:00Z

Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials
Business
Illumina targets cancer diagnostics

2014-08-22T00:00:00Z

Sequencing will improve tests and speed up clinical trials processes for big pharma partners